Semi-Annual Statement Of Income And Retained Earnings

Delta-Fly Pharma, Inc. - Filing #7320763

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-1,403,464,000 JPY
-1,315,810,000 JPY
Non-operating income
Non-operating income
16,000 JPY
45,000 JPY
Non-operating expenses
Non-operating expenses
23,443,000 JPY
9,995,000 JPY
Ordinary profit (loss)
-1,426,891,000 JPY
-1,325,760,000 JPY
Profit (loss) before income taxes
-1,426,891,000 JPY
-1,325,760,000 JPY
Income taxes - current
2,502,000 JPY
3,028,000 JPY
Profit (loss)
-1,429,393,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY
-1,328,788,000 JPY
-1,328,788,000 JPY
-1,328,788,000 JPY
-1,328,788,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.